Literature DB >> 26927248

Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study.

Li-Hong Wei1, Wen-Hong Ma1, Ni Tang1, Ji-Hong Wei2.   

Abstract

OBJECTIVE: Poor ovarian response to ovarian hyperstimulation is one of the biggest challenges in assisted reproduction technology. Although many stimulation protocols have been established to improve clinical outcomes in poor ovarian responders (PORs), which protocol is the most effective remains controversial. Luteal-phase ovarian stimulation (LPOS) has been used in normal ovarian responders with satisfactory outcomes. However, the efficacy of LPOS in PORs is unclear. This study aimed to compare the efficacy of LPOS and GnRH antagonist (GnRH-ant) in PORs.
MATERIALS AND METHODS: The clinical parameters in PORs who received LPOS (50 cycles in 39 patients) or GnRH-ant (158 cycles in 123 patients) were compared.
RESULTS: Compared with those in the GnRH-ant group, the PORs in the LPOS group showed significantly fewer basal antral follicles (3.1 ± 2.2 vs. 4.1 ± 1.6, p < 0.001) and a higher in vitro fertilization rate. There were no significant differences in the numbers of retrieved oocytes and D3 transferable embryos between the two groups. However, the pregnancy rate in the LPOS group (46.4%) was significantly higher than that in the GnRH-ant group (25.8% overall; 22.9% from fresh embryos and 29.6% from frozen embryos). Moreover, 23 PORs in the LPOS group underwent oocyte retrieval twice in one cycle, and the numbers of retrieved oocytes and transferable embryos from the luteal phase were significantly higher than those from the follicular phase in the same menstrual cycle.
CONCLUSIONS: Compared with the GnRH-ant protocol, the LPOS protocol may be a better regime for PORs that can increase the numbers of retrieved oocytes and transferable embryos as well as the pregnancy rate.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  GnRH antagonist; in vitro fertilization–embryo transfer; luteal-phase ovarian stimulation; poor ovarian responder

Mesh:

Substances:

Year:  2016        PMID: 26927248     DOI: 10.1016/j.tjog.2015.07.001

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  4 in total

Review 1.  ART outcomes following ovarian stimulation in the luteal phase:a systematic review and meta-analysis.

Authors:  Buo-Jia Lu; Chien-Ju Lin; Bou-Zenn Lin; Li Huang; Li-Ting Chien; Chi-Huang Chen
Journal:  J Assist Reprod Genet       Date:  2021-05-25       Impact factor: 3.357

2.  Can ovarian double-stimulation in the same menstrual cycle improve IVF outcomes?

Authors:  Maria Cecília de Almeida Cardoso; Alessandra Evangelista; Cássio Sartório; George Vaz; Caio Luis Vieira Werneck; Fernando Marques Guimarães; Paulo Gallo de Sá; Maria Cecília Erthal
Journal:  JBRA Assist Reprod       Date:  2017-09-01

3.  Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial.

Authors:  Joaquín Llácer; Belén Moliner; Lydia Luque; Andrea Bernabéu; Belén Lledó; Juan Carlos Castillo; Jaime Guerrero; Jorge Ten; Rafael Bernabéu
Journal:  Reprod Biol Endocrinol       Date:  2020-02-07       Impact factor: 5.211

4.  DuoStim - a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes. A systematic review.

Authors:  Alberto Vaiarelli; Danilo Cimadomo; Cecilia Petriglia; Alessandro Conforti; Carlo Alviggi; Nicolò Ubaldi; Sergio Ledda; Susanna Ferrero; Laura Rienzi; Filippo Maria Ubaldi
Journal:  Ups J Med Sci       Date:  2020-04-25       Impact factor: 2.384

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.